echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 9 pharmaceutical companies involved in bribery cases In the field of anti-corruption continued high pressure.

    9 pharmaceutical companies involved in bribery cases In the field of anti-corruption continued high pressure.

    • Last Update: 2020-09-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical Network August 17th, China's judicial documents network published the "Liu Ocean corruption crime first instance criminal judgment" shows that from 2014 to 2018, the former Gansu Provincial Drug Administration Review and Certification Center Director Liu Hai used his position to provide pharmaceutical enterprises in GMP, GSP certification and on-site inspection and other aspects of help, illegal acceptance of Lanzhou Taibao Pharmaceutical Co., Ltd. and other 9 pharmaceutical companies bribes.
    the judgment, Liu Ocean illegally received calligraphy works worth a total of 69,000 yuan and 63,250 yuan from others.
    , Liu Hai was sentenced to five years in prison and fined 400,000 yuan for corruption and bribery.
    the same time, two calligraphy works with a value of RMB 831,220 and RMB63,250 seized in the case shall be confiscated in accordance with the law and handed over to the State Treasury.
    9 pharmaceutical companies involved in bribery case response is mostly very vague recently, the reporter called the case of 9 pharmaceutical companies to understand the situation.
    Lanzhou Taibao Pharmaceutical Co., Ltd. staff said they were not aware of the incident, Gansu Taikang Pharmaceutical Co., Ltd. staff made it clear that "we do not accept interviews", Gansu Province Xifeng Pharmaceutical Co., Ltd. staff said they do not understand the situation, Gansu Fuzheng Pharmaceutical Technology Co., Ltd. staff said they did not understand the incident, after replying to reporters, Lanzhou Fuci Pharmaceutical Co., Ltd. staff said "this is a personal act, has criticized education."
    the other four drug companies in the united states remain unanswered.
    Lanzhou Taibao Pharmaceutical Legal Person bribed 10,000 yuan The company said it was not aware of the incident in July 2014, Liu Ocean for Lanzhou Taibao Pharmaceutical Co., Ltd. through GMP certification to help, received the company's legal representative, General Manager Wang sent 10,000 yuan in cash.
    reporters on the relevant issues called Lanzhou Taibao Pharmaceutical Co. , Ltd. official website to provide contact telephone to understand the situation, the other side told reporters that they are sales staff, not clear about the incident.
    when asked if he could provide a phone call from his company's office, the staff member said he could not find a phone number from the human resources department and was a new staff member.
    Gansu Taikang Pharmaceuticals bribed 5000 yuan The company said "we do not accept interviews" in August 2015, Liu Ocean for Gansu Taikang Pharmaceutical Co., Ltd. new plant through certification inspection to help, received the company's technical head Mao sent 5000 yuan in cash.
    called Gansu Taikang Pharmaceutical Co., Ltd. to understand the situation, the company's staff made it clear that "we do not accept interviews."
    Xifeng Pharmaceuticals, Gansu Province, paid a bribe of 10,000 yuan In May 2016, Liu Hai provided assistance to Xifeng Pharmaceutical Co., Ltd. of Gansu Province in handling medical advertising, and received 10,000 yuan in cash from Guo, general manager of the company.
    reporters on the relevant issues called Xifeng Pharmaceutical Co., Ltd. in Gansu Province, the other side of the Integrated Management Department of a staff member said he did not understand the situation.
    Tianshui Top Sheng pharmaceutical legal person bribed the value of 63250 yuan 2 calligraphy works Company phone calls were not answered in July 2016, Liu Ocean for Tianshui Top Sheng Pharmaceutical Co., Ltd. to arrange advance certification time and other assistance, receiving the company's legal representative Xue Difeng sent 63,250 yuan worth of 2 calligraphy works.
    reporter repeatedly called Tianshui Top Sheng Pharmaceutical Co. , Ltd. , its phone has not been answered.
    Gansu Run Fengyuan Agricultural and Pastoral Eco-Technology Chairman 3 times bribed 14,000 yuan Company phone calls no answer to the 2017 Spring Festival to 2018 Spring Festival, Liu Ocean for Gansu Run Fengyuan Agricultural and Pastoral Eco-Technology Co., Ltd. in GMP certification to help, has received three times the company's Chairman Yan a total of 14,000 yuan in cash.
    reporters on related issues to call Gansu Run Fengyuan Agricultural and Livestock Eco-Technology Co., Ltd., its phone was not answered.
    Gansu Fuzheng Pharmaceuticals bribed 5000 yuan The company said to understand the situation after replying to the end of 2017, Liu Ocean for Gansu Fuzheng Pharmaceutical Technology Co., Ltd. in the relevant certification to help, received the company's general manager Xi a cash delivery of 5000 yuan.
    reporters on related issues to call their office leaders, the other side said that they do not know about the incident, to understand the reporter.
    , as of the time of writing, the reporter has not received a reply.
    Gansu Furen Pharmaceutical bribe 5000 yuan company phone no answer to the 2018 Spring Festival, Liu Ocean for Gansu Furen Pharmaceutical Technology Co., Ltd. in the workshop transformation, certification to help, has twice received the company's boss Cao a cash 5000 yuan.
    called Gansu Furen Pharmaceutical Technology Co., Ltd. on related issues, and his phone was not answered.
    Tianshui Qi Huang Pharmaceutical Co., Ltd. Chairman bribed 10,000 yuan Company phone calls no answer in July 2018, Liu Ocean for Tianshui Qi Huang Pharmaceutical Company through GMP certification to help, received the company's legal representative, Chairman Yan a cash delivery of 10,000 yuan.
    reporter repeatedly called Tianshui Qi Huang Pharmaceutical Co., Ltd. to understand the problem, and his phone was never answered.
    Foci Pharmaceuticals bribed 10,000 yuan company said that "this is a personal act has criticized education" In September 2018, Liu Ocean for Lanzhou Fuci Pharmaceutical Co., Ltd. plant relocation of the new area after the successful on-site inspection to help, received the company's deputy general manager Chai a cash delivery of 10,000 yuan.
    August 14, the reporter called Lanzhou Fuci Pharmaceutical Co., Ltd., the other side of wang surname staff told reporters that at that time, the on-site inspection has passed the expert certification, but because of the former Gansu Provincial Drug Administration review certification center director Liu Ocean's "difficulty", its GMP certificate has not been issued down.
    , when its old factory products have been sold out, the situation is more urgent, so the company's deputy general manager Chai had to bribe 10,000 yuan in cash.
    " this is a personal act, he has been the corresponding criticism of education, our company does not have any other bribery.
    " the staff member introduced, affected by this incident, the company's original number one Gansu integrity enterprise honor was also recently withdrawn (not yet public), its customers and honor has a great impact.
    Nine Ministries: Deep investigation into corruption in the field of medicine and medicine directly infringes on the interests of the state and the people, erodes the people's sense of well-being, well-being and security, is hindering the deepening of medical reform, the implementation of a healthy China strategy is one of the persistent diseases.
    resolutely investigate and punish serious disciplinary violations in the field of medicine, and has always been the focus of the problem of corruption around the masses.
    June 5 this year, the State Health Commission, the Ministry of Industry and Information Technology, the Ministry of Public Security and other nine ministries jointly issued "on the issuance of 2020 to correct the field of pharmaceutical purchase and sale and medical services in the wrong wind work points notice."
    The notice requires that the chain of management of pharmaceutical production and circulation be further strengthened, and that the red line of communication between pharmaceutical supplies operators and medical personnel be defined by regulating the cooperative behavior of medical and commercial enterprises, so as to clarify illegal acts, and that manufacturers and medical personnel who dare to violate them should be seriously dealt with, and that the focus areas of illegal acts in the early stages should be seriously combated.
    , we should deeply clean up the chaos of the medical industry around the masses.
    The review and investigation information issued by the local discipline commission and the information on the punishment of the Party discipline and government affairs also show that since this year, the coverage of anti-corruption of medicine has been further expanded, from major public hospitals, to clinical trial institutions, medical research institutes, to township hospitals, community health service centers, the relevant staff are included in the scope of strict inspection.
    reporters incomplete statistics, in July this year alone, six medical practitioners have been investigated for suspected serious violations of the law and discipline.
    According to the Jiangsu Provincial Commission for Discipline Inspection on July 30, Jiangsu Provincial Market Supervision Authority party group member, deputy director Ofu Luhong suspected of serious disciplinary violations, is currently subject to disciplinary review and supervision investigation;
    According to Qingliang Zhenjiang Network July 23, Yan Jinchuan, assistant dean of Jiangsu University Hospital, is suspected of serious disciplinary violations and is currently under disciplinary review and supervision investigation; Shi Qingping, director of the pharmacy department of the hospital, is currently under disciplinary review and supervision investigation, according to the website of the State Supervision Commission of the Central Commission for Discipline Inspection, July 1, Zhang Zhaofeng, director of the Biotechnology and Medicine Department of the Social Development Science and Technology Division of the Ministry of Science and Technology, is suspected of serious violations of the law, and is currently under supervision and investigation by the Discipline Inspection And Supervision Group of the State Supervision Committee of the Central Commission for Discipline Inspection in the Ministry of Science and Technology and the Tianjin Municipal Supervision Commission. Expert: Medical corruption is a complex chain of interests The main leaders have too much voice in recent years, with the gradual increase of the Party and the state anti-corruption efforts, the anti-corruption effect in the field of medicine is particularly remarkable.
    , but under the pressure of anti-corruption, there are still some corrupt elements against the wind.
    One industry insider, who did not want to be named, told the Economic Daily-China Economic Network that pharmaceutical corruption is a complex chain of interests, from pharmacies, pharmaceutical companies, pharmaceutical representatives, hospitals, to relevant departments, each side to "income-generating", individual corrupt elements will inevitably take "shortcuts."
    In his view, the emergence of the so-called chain of interests, on the one hand, is due to the existing health care system is not complete, the relevant policies are loopholes, giving illegal elements to take advantage of, on the other hand, the main managers and leaders have too much voice, is a major cause of corruption.
    August 4th, the website of the State Supervision Commission of the Central Commission for Discipline Inspection again issued a message stressing the need to dig deep into medical corruption.
    to cut the chain, strictly check the receipt of drug supplies rebates and other issues, to remove the dead end, the coverage of anti-corruption medicine continued to expand;
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.